-
EXECUTIVE SUMMARY 13
-
MARKET INTRODUCTION 14
-
SCOPE OF THE STUDY 14
-
RESEARCH OBJECTIVE 14
-
MARKET STRUCTURE
-
ASSUMPTIONS & LIMITATIONS 15
-
RESEARCH METHODOLOGY 16
-
DATA MINING 16
-
SECONDARY RESEARCH 17
-
PRIMARY RESEARCH 18
-
BREAKDOWN OF PRIMARY RESPONDENTS 19
-
FORECASTING TECHNIQUES 19
-
RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
-
BOTTOM-UP APPROACH
- TOP-DOWN APPROACH 22
-
DATA TRIANGULATION 23
-
VALIDATION
-
MARKET DYNAMICS 24
-
OVERVIEW 24
-
DRIVERS 25
-
GROWING DEMAND FOR BONE AND JOINT HEALTH INGREDIENTS IN FUNCTIONAL
-
FOOD &
-
BEVERAGES AND DIETARY SUPPLEMENTS 25
-
RISING DEMAND FOR BONE AND JOINT
-
HEALTH INGREDIENTS IN THE ELDERLY POPULATION 25
-
RISING PREVALENCE OF
-
ORTHOPEDIC DISEASES 26
-
RESTRAINT 27
- SIDE EFFECTS ASSOCIATED
-
WITH THE BONE AND JOINT INGREDIENTS 27
-
STRINGENT GOVERNMENT REGULATIONS
-
OPPORTUNITY 28
- UNTAPPED MARKETS IN DEVELOPING ECONOMIES 28
- ADOPTION OF GROWTH STRATEGIES BY KEY PLAYERS 29
- INFLUENCE OF
-
SOCIAL MEDIA AND INNOVATIVE MARKETING STRATEGIES 29
-
MARKET FACTOR ANALYSIS 30
-
VALUE CHAIN ANALYSIS 30
- R&D 31
- MANUFACTURING
- DISTRIBUTION 31
- MARKETING AND SALES 31
-
PORTER’S
-
FIVE FORCES MODEL 32
-
THREAT OF NEW ENTRANTS 33
- BARGAINING
-
POWER OF SUPPLIERS 33
-
THREAT OF SUBSTITUTES 33
- BARGAINING
-
POWER OF BUYERS 33
-
INTENSITY OF RIVALRY 33
-
COVID-19 IMPACT ANALYSIS
- IMPACT ON R&D 34
- IMPACT ON SUPPLY CHAIN 34
-
IMPACT ON RAW MATERIAL 34
-
IMPACT ON DEMAND AND SUPPLY 35
-
GLOBAL
-
BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE 36
-
OVERVIEW
-
CALCIUM 37
-
COLLAGEN 39
-
GLUCOSAMINE 40
-
CHONDROITIN
-
MAGNESIUM 42
-
VITAMINS 43
-
OTHERS 45
-
GLOBAL BONE
-
AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION 46
-
OVERVIEW 46
-
FOOD & BEVERAGES 47
-
PHARMACEUTICALS 48
-
NUTRACEUTICALS &
-
DIETARY SUPPLEMENTS 49
-
GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET, BY
-
REGION 50
-
OVERVIEW 50
-
NORTH AMERICA 52
- US 54
-
CANADA 55
-
MEXICO 56
-
EUROPE 57
- GERMANY 59
-
UK 60
-
FRANCE 61
- ITALY 62
- SPAIN 63
- REST
-
OF EUROPE 64
-
ASIA PACIFIC 65
- CHINA 67
- JAPAN 68
- INDIA 69
- AUSTRALIA & NEW ZEALAND 70
- REST OF ASIA-PACIFIC
-
REST OF THE WORLD 72
- SOUTH AMERICA 74
- MIDDLE EAST
- AFRICA 76
-
COMPETITIVE LANDSCAPE 77
-
OVERVIEW 77
-
COMPETITIVE BENCHMARKING 79
-
MAJOR GROWTH STRATEGY IN THE BONE AND
-
JOINT HEALTH INGREDIENT MARKET 80
-
THE LEADING PLAYER IN TERMS OF NUMBER
-
OF DEVELOPMENTS IN THE BONE AND JOINT HEALTH INGREDIENT MARKET 81
-
KEY DEVELOPMENT
-
ANALYSIS 81
-
KEY DEVELOPMENTS & GROWTH STRATEGIES 82
- PRODUCT
-
LAUNCH/ APPROVAL 82
-
COLLABORATION/EXPANSION/INVESTMENT/PARTNERSHIP 82
- MARKET PROMOTION/PRODUCT RECOGNITION/PRODUCT INCORPORATION 83
-
FINANCIAL
-
MATRIX 84
-
SALES (USD MILLION), 2023 84
- R&D EXPENDITURE
-
(USD MILLION), 2023 84
-
COMPANY PROFILES 85
-
KONINKLIJKE
-
DSM N.V. (ROYAL DSM) 85
-
COMPANY OVERVIEWS 85
- FINANCIAL OVERVIEW
- PRODUCTS/SERVICES OFFERED 87
- KEY DEVELOPMENTS 87
-
SWOT ANALYSIS 88
-
KEY STRATEGIES 88
-
BASF SE 89
-
COMPANY OVERVIEW 89
-
FINANCIAL OVERVIEW 90
- PRODUCTS/SERVICES
-
OFFERED 90
-
KEY DEVELOPMENTS 91
- SWOT ANALYSIS 91
-
KEY STRATEGIES 91
-
ARCHER DANIELS MIDLAND 92
- COMPANY OVERVIEWS
- FINANCIAL OVERVIEW 93
- PRODUCTS/SERVICES OFFERED 93
- KEY DEVELOPMENTS 93
- SWOT ANALYSIS 94
- KEY STRATEGIES
-
GLANBIA PLC 95
- COMPANY OVERVIEWS 95
- FINANCIAL
-
OVERVIEW 96
-
PRODUCTS/SERVICES OFFERED 96
- KEY DEVELOPMENTS
- SWOT ANALYSIS 97
- KEY STRATEGIES 97
-
LONZA GROUP
- COMPANY OVERVIEWS 98
- FINANCIAL OVERVIEW 99
-
PRODUCTS/SERVICES OFFERED 99
-
KEY DEVELOPMENTS 100
- SWOT ANALYSIS
- KEY STRATEGIES 101
-
BIOIBERICA S.A.U. 102
- COMPANY OVERVIEWS 102
- FINANCIAL OVERVIEW 102
- PRODUCTS/SERVICES
-
OFFERED 102
-
KEY DEVELOPMENTS 103
- SWOT ANALYSIS 103
-
KEY STRATEGIES 104
-
STRATUM NUTRITION 105
- COMPANY OVERVIEW
- FINANCIAL OVERVIEW 105
- PRODUCTS/SERVICES OFFERED 105
- KEY DEVELOPMENTS 105
- KEY STRATEGIES 105
-
PHARMAZEN
-
LIMITED (WAITAKI BIO) 106
-
COMPANY OVERVIEW 106
- FINANCIAL
-
OVERVIEW 106
-
PRODUCTS/SERVICES OFFERED 107
- KEY DEVELOPMENTS
- KEY STRATEGIES 107
-
DARLING INGREDIENTS (ROUSSELOT) 108
- COMPANY OVERVIEW 108
- FINANCIAL OVERVIEW 109
- PRODUCTS/SERVICES
-
OFFERED 109
-
KEY DEVELOPMENTS 110
- KEY STRATEGIES 110
-
HOLISTA COLLTECH 111
-
COMPANY OVERVIEWS 111
- FINANCIAL OVERVIEW
- PRODUCTS/SERVICES OFFERED 112
- DEVELOPMENTS 113
- KEY STRATEGIES 113
-
APPENDIX 114
-
REFERENCES 114
-
RELATED REPORTS 114
-
& LIMITATIONS 15
-
2032 (USD MILLION) 37
-
AND TO MAINTAIN ADEQUATE
-
RATES OF CALCIUM RETENTION IN HEALTHY PEOPLE 37
-
JOINT HEALTH INGREDIENT MARKET, FOR CALCIUM, BY REGION, 2023-2032 (USD MILLION)
-
REGION, 2023-2032 (USD MILLION) 39
-
MARKET, FOR GLUCOSAMINE, BY REGION, 2023-2032 (USD MILLION) 40
-
BONE AND JOINT HEALTH INGREDIENT MARKET, FOR CHONDROITIN, BY REGION, 2023-2032 (USD
-
MILLION) 41
-
HEALTHY PEOPLE 42
-
FOR MAGNESIUM, BY REGION, 2023-2032 (USD MILLION) 43
-
RECOMMENDED AMOUNTS OF VITAMIN C FOR DIFFERENT AGES IN MILLIGRAMS (MG) 43
-
DAILY UPPER LIMITS FOR VITAMIN C CONSUMPTION (MG) 44
-
CONTENT OF SELECTED FOODS 44
-
MARKET, FOR VITAMINS, BY REGION, 2023-2032 (USD MILLION) 45
-
BONE AND JOINT HEALTH INGREDIENT MARKET, FOR OTHERS, BY REGION, 2023-2032 (USD MILLION)
-
2032 (USD MILLION) 46
-
MARKET FOR FOOD & BEVERAGES, BY REGION, 2023-2032 (USD MILLION) 47
-
GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR PHARMACEUTICALS, BY REGION,
-
2032 (USD MILLION) 48
-
MARKET, FOR NUTRACEUTICALS & DIETARY
-
SUPPLEMENTS, BY REGION, 2023-2032,
-
(USD MILLION) 49
-
BY REGION, 2023-2032 (USD MILLION) 51
-
HEALTH INGREDIENT MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 52
-
AMERICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032
-
(USD MILLION) 53
-
BY APPLICATION, 2023-2032 (USD MILLION) 54
-
INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 54
-
US: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2023-2032 (USD MILLION)
-
TYPE, 2023-2032 (USD MILLION) 55
-
MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 55
-
JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 56
-
(USD MILLION) 56
-
BY COUNTRY, 2023-2032 (USD MILLION) 57
-
INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 58
-
EUROPE: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2023-2032 (USD
-
MILLION) 59
-
TYPE, 2023-2032 (USD MILLION) 59
-
MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 59
-
HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 60
-
UK: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2023-2032 (USD MILLION)
-
TYPE, 2023-2032 (USD MILLION) 61
-
MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 61
-
JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 62
-
(USD MILLION) 62
-
INGREDIENT TYPE, 2023-2032 (USD MILLION) 63
-
HEALTH INGREDIENT MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 63
-
REST OF EUROPE: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE,
-
2032 (USD MILLION) 64
-
MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 64
-
AND JOINT HEALTH INGREDIENT MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 65
-
ASIA-PACIFIC: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032
-
(USD MILLION) 66
-
BY APPLICATION, 2023-2032 (USD MILLION) 67
-
INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 67
-
CHINA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2023-2032 (USD MILLION)
-
2032 (USD MILLION) 68
-
MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 68
-
JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 69
-
(USD MILLION) 69
-
INGREDIENT MARKET,
-
BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 70
-
AUSTRALIA & NEW ZEALAND: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION,
-
2032 (USD MILLION) 70
-
INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 71
-
REST OF ASIA-PACIFIC: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2023-2032
-
(USD MILLION) 71
-
MARKET, BY REGION, 2023-2032 (USD MILLION) 72
-
AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION)
-
APPLICATION, 2023-2032 (USD MILLION) 73
-
HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 74
-
SOUTH AMERICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2023-2032
-
(USD MILLION) 74
-
BY INGREDIENT TYPE, 2023-2032 (USD MILLION) 75
-
JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 75
-
AFRICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023-2032
-
(USD MILLION) 76
-
BY APPLICATION, 2023-2032 (USD MILLION) 76
-
THE BONE AND JOINT HEALTH INGREDIENT MARKET 78
-
IN THE BONE AND JOINT HEALTH INGREDIENT MARKET 81
-
APPROVAL 82
-
MARKET PROMOTION/PRODUCT RECOGNITION/PRODUCT INCORPORATION 83
-
PRODUCTS/SERVICES OFFERED 87
-
BASF SE: PRODUCTS/SERVICES OFFERED 90
-
OFFERED 96
-
PRODUCTS/SERVICES OFFERED 99
-
S.A.U.: KEY DEVELOPMENTS 103
-
OFFERED 105
-
PHARMAZEN LIMITED: KEY DEVELOPMENTS 107
-
OFFERED 109
-
HOLISTA COLLTECH: PRODUCTS/SERVICES OFFERED 112
-
MARKET 14
-
GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET 24
-
ANALYSIS 26
-
ANALYSIS: GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET 30
-
FIVE FORCES ANALYSIS: GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET 32
-
GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2023 &
-
(USD MILLION) 36
-
BY APPLICATION, 2023 & 2027 (USD MILLION) 46
-
JOINT HEALTH INGREDIENT MARKET, BY REGION 2023 & 2027 (USD MILLION) 50
-
GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET SHARE (%), BY REGION, 2023 51
-
COUNTRY 2023 53
-
(%), BY COUNTRY, 2023 58
-
MARKET SHARE (%), BY COUNTRY, 2023 66
-
JOINT HEALTH INGREDIENT MARKET SHARE (%), BY REGION, 2023 72
-
OF MAJOR COMPETITORS 79
-
THE BONE AND JOINT HEALTH INGREDIENT MARKET 80
-
HEALTH INGREDIENT MARKET: COMPETITIVE LANDSCAPE 81
-
DSM: FINANCIAL OVERVIEW SNAPSHOT 86
-
BASF SE: FINANCIAL OVERVIEW SNAPSHOT 90
-
PLC.: SWOT ANALYSIS 97
-
ANALYSIS 103
-
HOLISTA COLLTECH: FINANCIAL OVERVIEW SNAPSHOT 112